- Direct Coronavirus, latest news
Not everything has been bad news in the stock market crisis unleashed by the coronavirus. Amid the collapses that have accumulated equities since mid-February, some companies have come out stronger. And it has logic. We already talked here about the manufacturers of masks and gloves , for example, and now it's the turn of manufacturers of respirators, hospital beds and, again, treatments to deal with the Covid-19.
Gilead
The latest big rise has been starring Gilead Sciences , an American biotech company dedicated to researching, developing, and marketing drugs to treat disease. On Thursday, the positive results obtained from a clinical trial of its antiviral 'Remdesivir' , which is being tested in patients seriously affected by viral disease, came out.
The STAT News website reported those advances and the news caused the firm's shares to shoot up more than 16% in the market outside Wall Street hours. Faced with the euphoria, the company called for caution and assured that they must "wait until the data from the ongoing studies are available."
Despite this, the shares shot up around 7% in yesterday's session. Since the beginning of the year, the company's shares have appreciated more than 25%, from just over 65 dollars that marked in early 2020 to almost 82 dollars at which it closed yesterday; only during the stock market bleeding has it gained 17%.
The laboratory plans to present its accounts on April 30 after the closing of the markets in the US.
Drägerwerk
It is one of the big winners of these movements in the markets. It is a German firm that develops equipment for medical applications and among them, respirators .
Its evolution in the Stock Market has been parallel to the need and urgency of this type of device in countries around the world. Its shares marked a little more than 52.5 euros at the beginning of the stock market crisis and this Friday closed at 77.2; They accumulate, therefore, a rise of 47% in just two months, although it reached a profit of 87% at the end of March and since then it has been correcting its value.
The CEO of the firm, Stefan Dräger , recently acknowledged to the Financial Times that they had received voluminous orders in recent weeks from different countries and drew attention to the factories that have been converted, in an almost obligatory and temporary way, to manufacture respirators within countries. "It seems like a good initiative on his part, but I'm skeptical about the results," he said.
Fisher & Paykel Healthcare
Fisher & Paykel Healthcare , a New Zealand company specialized in designing and marketing products and systems for use in respiratory care, is part of the same segment .
Its actions since the beginning of the year draw a comeback from Australian $ 22 to the current 30, 36% more. If reference is made to February 24, the first black Monday caused by the coronavirus, the comeback remains at 15%, a not inconsiderable percentage considering the double-digit falls that accumulate most of the most important indexes of all the world
Arjo
Swedish company of manufacturer of beds for hospitals , the titles of Arjo finished this Friday in 55.8 SEK, compared to 45.7 that marked at the beginning of the year. Its shares began to rise when the first news of a strange disease in China reached Europe and peaked at almost 57 crowns in mid-February, up 24%. Now its value has corrected some positions and the balance during the coronavirus crisis leaves it with a positive balance of more than 10%.
According to the criteria of The Trust Project
Know more- Coronavirus
- Covid 19
MacroeconomicsEuropean stock markets expand their comeback and the Ibex remains on the verge of recovering the 7,000
Companies The Government prohibits investors from outside the EU from buying more than 10% of Spanish companies
Investment Stock markets barely flinch and fall again after latest Fed stimulus package